Compare Ciputra Development Tbk (CTRA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ciputra Development Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Ciputra Development Tbk trades at Rp595 (market cap 11.31T, 6.71M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Ciputra Development Tbk is far larger — about 35.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (6.71M versus 41.7K). Which is the better fit depends on your goals.
| CTRA | DGNS | |
|---|---|---|
Market Cap | 11.31T | 316.25B |
Volume | 6.71M | 41.7K |
Lot | 67.06K | 417 |
Turnover | 4.02B | 9.66M |
Average Price | 598.92 | 231.65 |
Value | 4.02B | 9.66M |
Indicative Equilibrium Price | 595 | 230 |
Indicative Equilibrium Volume | 732 | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ciputra Development Tbk
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
